Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 15,164 | 11,715 | 14,599 | 17,629 | 21,563 |
| Operating Income | -15,164 | -11,715 | -14,599 | -17,629 | -21,563 |
| Interest Expense | 0 | 0 | 302 | 347 | 0 |
| Other Income | 618 | 488 | 1,197 | 1,420 | 1,345 |
| Pre-tax Income | -14,546 | -11,227 | -13,704 | -16,556 | -20,218 |
| Net Income Continuous | -14,546 | -11,227 | -13,704 | -16,556 | -20,218 |
| Net Income | $-14,546 | $-11,227 | $-13,704 | $-16,556 | $-20,218 |
| EPS Basic Total Ops | -1.99 | -1.53 | -1.87 | -2.27 | -2.77 |
| EPS Basic Continuous Ops | -1.98 | -1.53 | -1.87 | -2.27 | -2.77 |
| EPS Diluted Total Ops | -1.99 | -1.53 | -1.87 | -2.27 | -2.77 |
| EPS Diluted Continuous Ops | -1.98 | -1.53 | -1.87 | -2.27 | -2.77 |
| EPS Diluted Before Non-Recurring Items | -1.99 | -1.53 | -1.87 | -2.27 | -2.77 |
| EBITDA(a) | $-15,283 | $-11,945 | $-14,901 | $-17,907 | $-22,153 |